Charles Schwab Investment Management Inc Trans Medics Group, Inc. Transaction History

Charles Schwab Investment Management Inc

$515 Billion
Q3 2024

A detailed history of Charles Schwab Investment Management Inc transactions in Trans Medics Group, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 271,694 shares of TMDX stock, worth $18.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

271,694

Previous 265,060 2.5%

Holding current value

$18.8 Million

Previous $39.9 Million 6.84%

% of portfolio

0.01%

Previous 0.01%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$135.68 - $176.11 $900,101 - $1.17 Million	6,634 Added 2.5%	271,694 $42.7 Million
Q2 2024 Aug 12, 2024	BUY	$72.62 - $150.62 $561,788 - $1.17 Million	7,736 Added 3.01%	265,060 $39.9 Million
Q1 2024 May 08, 2024	BUY	$70.86 - $89.93 $269,764 - $342,363	3,807 Added 1.5%	257,324 $19 Million
Q4 2023 Feb 06, 2024	BUY	$36.74 - $81.08 $159,561 - $352,130	4,343 Added 1.74%	253,517 $20 Million
Q3 2023 Nov 08, 2023	BUY	$53.47 - $96.07 $437,170 - $785,468	8,176 Added 3.39%	249,174 $13.6 Million
Q2 2023 Aug 09, 2023	BUY	$66.23 - $88.73 $485,730 - $650,745	7,334 Added 3.14%	240,998 $20.2 Million
Q1 2023 May 11, 2023	BUY	$53.63 - $82.33 $5,952 - $9,138	111 Added 0.05%	233,664 $17.7 Million
Q4 2022 Feb 13, 2023	BUY	$39.08 - $64.29 $294,663 - $484,746	7,540 Added 3.34%	233,553 $14.4 Million
Q3 2022 Nov 14, 2022	BUY	$31.56 - $55.75 $1 Million - $1.77 Million	31,708 Added 16.32%	226,013 $9.43 Million
Q2 2022 Aug 15, 2022	SELL	$20.56 - $32.15 $134,626 - $210,518	-6,548 Reduced 3.26%	194,305 $6.11 Million
Q1 2022 May 13, 2022	BUY	$12.58 - $26.94 $102,162 - $218,779	8,121 Added 4.21%	200,853 $5.41 Million
Q4 2021 Feb 11, 2022	BUY	$19.16 - $32.68 $72,788 - $124,151	3,799 Added 2.01%	192,732 $3.69 Million
Q3 2021 Nov 16, 2021	BUY	$25.92 - $34.51 $435,067 - $579,250	16,785 Added 9.75%	188,933 $6.25 Million
Q2 2021 Aug 16, 2021	BUY	$21.63 - $40.07 $126,427 - $234,209	5,845 Added 3.51%	172,148 $5.71 Million
Q1 2021 May 17, 2021	BUY	$17.75 - $47.82 $117,256 - $315,898	6,606 Added 4.14%	166,303 $6.9 Million
Q4 2020 Feb 16, 2021	SELL	$11.91 - $19.9 $9,218 - $15,402	-774 Reduced 0.48%	159,697 $3.18 Million
Q3 2020 Nov 13, 2020	BUY	$13.78 - $18.84 $1.21 Million - $1.65 Million	87,548 Added 120.06%	160,471 $2.21 Million
Q2 2020 Aug 14, 2020	BUY	$11.66 - $18.26 $226,542 - $354,773	19,429 Added 36.32%	72,923 $1.31 Million
Q1 2020 May 15, 2020	BUY	$10.5 - $20.2 $5,628 - $10,827	536 Added 1.01%	53,494 $647,000
Q4 2019 Feb 07, 2020	BUY	$16.61 - $21.64 $217,059 - $282,791	13,068 Added 32.76%	52,958 $1.01 Million
Q3 2019 Nov 08, 2019	BUY	$20.27 - $28.93 $40,398 - $57,657	1,993 Added 5.26%	39,890 $948,000
Q2 2019 Aug 09, 2019	BUY	$22.36 - $30.41 $847,376 - $1.15 Million	37,897 New	37,897 $1.1 Million

Others Institutions Holding TMDX

# of Institutions

397

Shares Held

31.7M

Call Options Held

466K

Put Options Held

286K

View Full List

About TransMedics Group, Inc.

Ticker TMDX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 31,831,400
Market Cap $2.2B
Description
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and custo...

More about TMDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Charles Schwab Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Charles Schwab Investment Management Inc with notifications on news.

Account

Charles Schwab Investment Management Inc Trans Medics Group, Inc. Transaction History